Current Medical Science

, Volume 38, Issue 4, pp 602–609 | Cite as

Association of Bone Turnover Levels with MTHFR Gene Polymorphisms among Pregnant Women in Wuhan, China

  • Shu-yun Liu
  • Qin Huang
  • Xue Gu
  • Bin Zhang
  • Wei Shen
  • Ping Tian
  • Yun Zeng
  • Ling-zhi Qin
  • Lin-xiang Ye
  • Ze-min Ni
  • Qi WangEmail author


Pregnancy is a critical stimulator of bone mineral resorption. We used to find the MTHFR gene polymorphisms are related with blood lead levels among pregnant women. Pregnancy-stimulated bone turnover may be associated with MTHFR gene polymorphisms too. In this article, we aimed to determine the relationship between MTHFR gene polymorphisms and bone turnover rates among the pregnant women. The participants including pregnant and non-pregnant women were selected and recruited during their routine prenatal or physical examination from July to October in 2012. A total of 1000 participants, including 250 pregnant women in the first, second, and third trimesters and 250 non-pregnant women, were enrolled in the study. Finally, after excluding 27 participants unable to provide blood samples, 973 eligible participants (i.e., 234,249, and 248 pregnant women in the first, second, and third trimesters, respectively, and 242 non-pregnant women) were included in the research. The MTHFR gene 1298CC homozygote carriers were more susceptible to yield higher plasma homocysteine levels than the 1298AA/AC carriers, with standardized coefficients of 0.086 (P<0.05) and 0.104 (P<0.01) of all the participants and the pregnant women, respectively. The MTHFR gene 1793AA homozygote carriers more likely showed higher plasma osteocalcin levels (standardized β=0.091,P<0.01) than the 1793GG/GA carriers among all the subjects. Plasma homocysteine levels were positively correlated with blood lead levels among the participants and the pregnant women with standardized coefficients of 0.320 (P<0.01) and 0.179 (P<0.01), respectively. Plasma osteocalcin levels were positively associated with blood lead levels among pregnant and non-pregnant women with standardized coefficients of 0.084 (P<0.05) and 0.125 (P<0.01), respectively. In conclusion, homocysteine and osteocalcin contents in plasma are associated with the MTHFR gene A1298C polymorphism and blood lead levels among pregnant women. The MTHFR gene A1298C polymorphism-related homocysteine is a possible risk factor for increased blood lead levels among Chinese women.

Key words

pregnant women bone turnover levels blood lead levels MTHFR gene polymorphism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



We thank the doctors, nurses and other staff working at Wuhan Women and Children Medical Health Center for their help to conduct this research.


  1. 1.
    Sanz-Salvador L, Garcia-Perez MA, Tarin JJ, et al. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol, 2015, 172(2):R53–65CrossRefPubMedGoogle Scholar
  2. 2.
    Abrams SA. Normal acquisition and loss of bone mass. Horm Res, 2003, 60(Suppl 3):71–76Google Scholar
  3. 3.
    Ettinger AS, Hu H, Hernandez-Avila M. Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation. J Nutr Biochem, 2007, 18(3):172–178CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Tellez-Rojo MM, Hernandez-Avila M, Lamadrid-Figueroa H, et al. Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol, 2004, 160(7):668–678CrossRefPubMedGoogle Scholar
  5. 5.
    Gundacker C, Hengstschlager M. The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr, 2012, 162(9–10):201–206CrossRefPubMedGoogle Scholar
  6. 6.
    Bellinger DC. Teratogen update: lead and pregnancy. Birth Defects Res A Clin Mol Teratol, 2005, 73(6):409–420CrossRefPubMedGoogle Scholar
  7. 7.
    Wang H, Liu C. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporos bit, 2012, 23(11):2625–2634CrossRefGoogle Scholar
  8. 8.
    Huang QY, Li GH, Kung AW. Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese. Bone, 2009, 44(5):984–988CrossRefPubMedGoogle Scholar
  9. 9.
    Urano T, Inoue S. Genetics of osteoporosis. Biochem Biophys Res Commun, 2014, 452(2):287–293CrossRefPubMedGoogle Scholar
  10. 10.
    Safarinejad MR, Safarinejad S, Shafiei N. Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset vasculogenic erectile dysfunction. Arch Med Res, 2010, 41(6):410–422CrossRefPubMedGoogle Scholar
  11. 11.
    Green TJ, McMahon JA, Skeaff CM, et al. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr, 2007, 85(2):460–464CrossRefPubMedGoogle Scholar
  12. 12.
    Abrahamsen B, Jorgensen HL, Nielsen TL, et al. MTHFR C.6770T polymorphism as an independent predictor of peak bone mass in Danish menresults from the Odense Androgen Study. Bone, 2006, 38(2):215–219CrossRefPubMedGoogle Scholar
  13. 13.
    Miyao M, Monta H, Hosoi T, et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int, 2000, 66(3):190–194CrossRefPubMedGoogle Scholar
  14. 14.
    Villadsen MM, Bunger MH, Carstens M, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int, 2005, 16(4):411–416CrossRefPubMedGoogle Scholar
  15. 15.
    Joerger M, Huober J (1st edition). Prevention of Bone Metastases: 192 (Recent Results in Cancer Research). Springer-Verlag Berlin Heidelberg, 2012, 234pCrossRefGoogle Scholar
  16. 16.
    Marshall WJ, Lapsley M, Day A, et al. Clinical Biochemistry: Metabolic and Clinical Aspects (3rd edition). Churchill Livingstone, 2014, 944pGoogle Scholar
  17. 17.
    Shen W, Zhang B, Liu S, et al. Association of blood lead levels with methylenetetrahydrofolate reductase polymorphisms among Chinese pregnant women in Wuhan city. PLoS One, 2015, 10(2):ell7366Google Scholar
  18. 18.
    Barbosa PR, Stabler SP, Machado AL, et al Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr, 2008, 62(8):1010–1021CrossRefPubMedGoogle Scholar
  19. 19.
    Chedraui P, Salazar-Pousada D, Villao A, et al. Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia. Gynecol Endocrinol, 2014, 30(5):392–396CrossRefPubMedGoogle Scholar
  20. 20.
    Poduri A, Mukheijee D, Sud K, et al. MTHFRA1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians. Mol Cell Biochem, 2008, 308(l–2):43–50Google Scholar
  21. 21.
    Kluijtmans LA, Young IS, Boreham CA, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood, 2003, 1 ol (7):2483–2488Google Scholar
  22. 22.
    van der Put NM, Gabreels F, Stevens EM, eia/.Asecond common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects? Am J Hum Genet, 1998, 62(5):1044–1051CrossRefGoogle Scholar
  23. 23.
    Hanson NQ, Aras О, Yang F, etal C677TandA1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem, 2001, 47(4):661–666PubMedGoogle Scholar
  24. 24.
    Li Z, Ren A, Zhang L, et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol, 2006, 76(4):237–240CrossRefPubMedGoogle Scholar
  25. 25.
    de Bree A, Verschuren WM, Bjorke-Monsen AL, et al. Effect of the methylenetetrahydrofolate reductase 677C~>T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr, 2003, 77(3):687–693CrossRefPubMedGoogle Scholar
  26. 26.
    Winkelmayer WC, Huber A, Wagner OF, et al. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int, 2005, 67(5):1980–1985CrossRefPubMedGoogle Scholar
  27. 27.
    Safarinejad MR, Shafiei N, Safarinejad S. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and Gl 793A) gene and risk of prostate cancer: a case-control study. Prostate, 2010, 70(15):1645–1657CrossRefPubMedGoogle Scholar
  28. 28.
    Chia SE, Ali SM, Lee BL, et al Association of blood lead and homocysteine levels among lead exposed subjects in Vietnam and Singapore. Occup Environ Med, 2007, 64(10):688–693CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Schafer JH, Glass TA, Bressler J, et al. Blood lead is a predictor of homocysteine levels in a populationbased study of older adults. Environ Health Perspect, 2005, 113(1):31–35CrossRefPubMedGoogle Scholar
  30. 30.
    Yakub M, Iqbal MP. Association of blood lead (Pb) and plasma homocysteine: a cross sectional survey in Karachi, Pakistan. PLoS One, 2010, 5(7):ell706Google Scholar
  31. 31.
    Krieg EJ, Butler MA. Blood lead, serumhomocysteine, and neurobehavioral test performance in the third National Health and Nutrition Examination Survey. Neurotoxicology, 2009, 30(2): 281–289CrossRefPubMedGoogle Scholar
  32. 32.
    van Guidener С, Stehouwer CD. Homocysteine metabolism in renal disease. Clin Chem Lab Med, 2003, 41(11):1412–1417Google Scholar
  33. 33.
    Machida M, Sun SJ, Oguma E, et al. High bone matrix turnover predicts blood levels of lead among perimenopausal women. Environ Res, 2009, 109(7):880–886CrossRefPubMedGoogle Scholar
  34. 34.
    Monir AU, Gundberg CM, Yagerman SE, et al. The effect of lead on bone mineral properties from female adult C57/BL6 mice. Bone, 2010, 47(5):888–894CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Milgram S, Carriere M, Thiebault C, et al. Cytotoxic and phenotypic effects of uranium and lead on osteoblastic cells are highly dependent on metal speciatioll. Toxicology, 2008, 250(1):62–69CrossRefPubMedGoogle Scholar
  36. 36.
    Tojo Y, Kurabayashi T, Honda A, et al. Bone structural and metabolic changes at the end of pregnancy and lactation in rats. Am J Obstet Gynecol, 1998, 178(1 Pt 1):180–185Google Scholar
  37. 37.
    Lees CJ, Jerome CP. Effects of pregnancy and lactation on bone in cynomolgus macaques: histomorphometric analysis of iliac biopsies. Bone, 1998, 22(5):545–549CrossRefPubMedGoogle Scholar
  38. 38.
    Dobnig H, Kainer F, Stepan V, et al. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab, 1995, 80(12):3699–3707CrossRefPubMedGoogle Scholar

Copyright information

© Huazhong University of Science and Technology 2018

Authors and Affiliations

  • Shu-yun Liu
    • 1
  • Qin Huang
    • 2
  • Xue Gu
    • 1
  • Bin Zhang
    • 3
  • Wei Shen
    • 2
  • Ping Tian
    • 2
  • Yun Zeng
    • 1
  • Ling-zhi Qin
    • 2
  • Lin-xiang Ye
    • 1
  • Ze-min Ni
    • 4
  • Qi Wang
    • 1
    Email author
  1. 1.Department of Epidemiology and Biostatistics, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.Department of Rehabilitation Medicine, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  3. 3.Wuhan Women and Children Medical Care CenterWuhanChina
  4. 4.Women and Children Medical Center of Jiang-an DistrictWuhanChina

Personalised recommendations